Trial Profile
Clofarabine, Cyclophosphamide and Etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 May 2012
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide; Etoposide
- Indications Leukaemia
- Focus Therapeutic Use
- 04 Jul 2011 New trial record